New coronary risk factors: Is there a difference between diabetic patients with microalbuminuria compared to those without microalbuminuria?

Medical Journal of Malaysia

Volumn 57, Issue 3, 2002, Pages 298-303

  Yeo, C K ^a   Hapizah, M N ^a   Khalid, B A K ^a   Wan Nazaimoon, W M ^b   Khalid, Y ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

^b INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

Author keywords

Diabetes mellitus; Microalbuminuria; New coronary risk factors

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; LIPOPROTEIN A;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DIABETES MELLITUS; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PREVALENCE; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALBUMINURIA; CORONARY ARTERIOSCLEROSIS; DIABETES COMPLICATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS;

EID: 0036762481     PISSN: 03005283     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Pyorala K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: An epidermiologic view. Diabetes Metab Rev 1987; 3: 463-73.
2. Witztum JL, Mahoney EM, Branks MJ, Fisher M, Elam R, Steinberg D. Nonezymatic glycosylation of low-density lipoprotein alters its biologic activity. Diabetes 1982; 31: 283-91.
3. Colwell JA, Winocour PD, Lopes-Virella M. New concepts about the pathogenesis of atherosclerosis in diabetes mellitus. Am J Med 1983; 75: 67-78.
4. Mattock MB, Morrish, NJ, Viberti, G, et al. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 1992; 41: 736.
5. Stehouwer, CD, Nauta, JJ, Zeldenrust, GC, et al. Urinary albumin excretion, cardiovascular disease and endothelial dysfunction in non insulin dependent diabetes mellitus. Lancet 1992; 340: 319.
6. Valmadrid, CT, Klein R, Moss SE, Klein BE. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older onset diabetes mellitus. Arch Intern Med 2000; 160: 1093.
7. Boston AG, Cupples LA, Jenner JL, et al. Elevated plasma lipoprotein (a) and coronary heart disease in men aged 55 years and younger: A prospective study. JAMA 1996; 276: 544-48.
8. Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: A metaanalysis and review of the literature. Ann Intern Med 1993; 118: 956.
9. Haffner SM. Lipoprotein (a) and diabetes: An update. Diabetes Care 1993; 16: 835-40.
10. Ernst E. Plasma fibrinogen - An independent cardiovascular risk factor. J Intern Med 1990; 227: 365-72.
11. Kannel WB, D'Agostino RB, Belanger AJ. Fibrinogen and risk for cardiovascular disease. JAMA 1987; 256: 1183-86.
12. Kannel WB, D'Agostino RB, Wilson PWF, et al. Diabetes, fibrinogen, and risk of cardiovascular disease: The Framingham experience. Am Heart J 1990; 120: 672.
13. Tracy RP, Lemaitre RN, Psaty BM, et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: Results from the Cardiovascular health Study and the Rural Health Promotion Project. Arteriosc Thromb Vasc Biol 1997; 17(6): 1121-7.
14. Schmitz A, Ingerslev J. Hemostatic measurements in type 2 diabetic patients with microalbuminuria. Diabet. Med. 1990; 7: 521-5.